Loading company details...
Latest Form 4 (Nov 17, 2026): Joseph Clay Thornton (Chief Financial Officer): Sale of 22,099 shares, $109.8K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 17, 2026 | Joseph Clay Thornton, Chief Financial Officer | Sale | 22,099 | $109.8K |
| Nov 6, 2026 | Joseph Frank Oldakowski, Chief Accounting Officer | Grant/Award | 186,403 | n/a |
| Nov 6, 2026 | Joseph Clay Thornton, Chief Financial Officer | Grant/Award | 328,947 | n/a |
| Oct 20, 2026 | Karen Soares, Chief Legal Officer | Sale | 19,275 | $89.8K |
| Oct 20, 2026 | Jamie L. Reynoso, CEO, Medicare Advantage | Sale | 4,066 | $17.9K |
| Oct 19, 2026 | Andrew Toy, Chief Executive Officer | Sale | 62,176 | $291.0K |
| Oct 19, 2026 | Karen Soares, Chief Legal Officer | Sale | 14,673 | $68.7K |
| Oct 19, 2026 | Joseph Clay Thornton, Interim CFO | Sale | 4,591 | $21.5K |
| Oct 19, 2026 | Conrad Wai, CEO, Counterpart Health | Sale | 23,627 | $110.6K |
| Oct 19, 2026 | Jamie L. Reynoso, CEO, Medicare Advantage | Sale | 18,273 | $85.5K |